Molecular Pathways: Overcoming Radiation Resistance by Targeting DNA Damage Response Pathways

Area of Science:

• Oncology
• Molecular Biology
• Radiation Biology

Background:

• Ionizing radiation causes DNA double-strand breaks, a primary mechanism of cancer cell killing.
• Tumor cells activate DNA damage response (DDR) pathways, including DNA repair and cell-cycle checkpoints, conferring radiation resistance.
• Targeting DDR pathways is a strategy to overcome radiation resistance and enhance radiotherapy efficacy.

Purpose of the Study:

• To review radiation-induced DNA damage responses.
• To discuss clinical advances in agents targeting DDR pathways.
• To explore synthetic lethality as a mechanism for tumor cell-selective radiosensitization.

Main Methods:

• Literature review of DNA damage response pathways.
• Analysis of clinical and translational studies on DDR inhibitors.
• Examination of synthetic lethality principles in cancer therapy.

Main Results:

• DDR pathways are crucial for tumor cell survival following radiation.
• Agents inhibiting DDR pathways show potential as radiosensitizers.
• Synthetic lethality provides a mechanism for selective targeting of tumor cells.

Conclusions:

• Inhibiting DNA damage response pathways is a promising strategy to enhance radiotherapy.
• Synthetic lethality offers a route to achieve tumor cell-selective radiosensitization.
• Combining DDR-targeted agents with radiotherapy may broaden the therapeutic window.